| In millions, except per share items | Jun-30-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Dec-30-21 | Sep-30-21 |
| | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 8-K | 10-Q |
| Revenues: |
| Industrial Injury Prevention Services Revenues | | 77.1 | 72.0 | 62.4 | 53.0 | 43.9 | | 40.2 |
| Physical Therapy Operations | | 476.1 | 469.8 | 465.7 | 461.4 | 451.1 | | 448.2 |
| Total revenues | | 553.1 | 541.8 | 528.1 | 514.4 | 495.0 | | 482.7 |
| Revenue growth [+] | | 11.7% | 12.3% | 13.4% | 21.7% | 17.0% | | 12.9% |
| Industrial Injury Prevention Services Revenues | | 75.5% | 79.2% | 57.1% | 34.6% | 12.0% | | 0.8% |
| Physical Therapy Operations | | 5.5% | 4.8% | 8.4% | 19.2% | 16.4% | | 16.2% |
| Cost of goods sold | | 319.2 | 312.2 | 300.9 | 289.8 | 278.5 | | 268.9 |
| Gross profit | | 234.0 | 229.6 | 227.2 | 224.6 | 216.6 | | 213.8 |
| Gross margin | | 42.3% | 42.4% | 43.0% | 43.7% | 43.7% | | 44.3% |
| Selling, general and administrative [+] | | 46.1 | 44.9 | 45.9 | 47.2 | 46.5 | | 46.7 |
| Sales and marketing | | | 34.2 | 35.2 | 36.5 | | | 35.8 |
| General and administrative | | 11.9 | | | | 10.7 | | |
| Equity in earnings | | 1.2 | 1.1 | 0.8 | 0.5 | 0.1 | | |
| Other operating expenses | | 121.9 | 118.2 | 112.8 | 106.7 | 99.4 | | 98.6 |
| EBITDA [+] | | 81.8 | 81.6 | 82.7 | 83.8 | 82.4 | | 79.4 |
| EBITDA growth | | -0.6% | 2.7% | 0.6% | 19.3% | 30.8% | | 23.7% |
| EBITDA margin | | 14.8% | 15.1% | 15.7% | 16.3% | 16.6% | | 16.5% |
| Depreciation | | 8.2 | 8.2 | 8.2 | 7.7 | 7.9 | | 7.4 |
| EBITA | | 73.6 | 73.3 | 74.5 | 76.2 | 74.5 | | 72.1 |
| EBITA margin | | 13.3% | 13.5% | 14.1% | 14.8% | 15.0% | | 14.9% |
| Amortization of intangibles | | 6.5 | 5.8 | 5.2 | 5.1 | 3.7 | | 3.6 |
| EBIT [+] | | 67.1 | 67.6 | 69.3 | 71.1 | 70.8 | | 68.5 |
| EBIT growth | | -5.2% | -1.3% | -3.1% | 19.2% | 35.0% | | 28.1% |
| EBIT margin | | 12.1% | 12.5% | 13.1% | 13.8% | 14.3% | | 14.2% |
| Non-recurring items | | 9.1 | | | | | | |
| Interest income | | 0.9 | 0.8 | 0.8 | 0.2 | 0.2 | | 0.2 |
| Interest income | | 0.9 | 0.8 | 0.8 | 0.2 | 0.2 | | 0.2 |
| Other income (expense), net [+] | | -3.3 | 1.0 | 1.2 | 2.5 | 2.2 | | 5.4 |
| Litigation settlement | | | | | | -2.6 | | |
| Pre-tax income | | 55.6 | 69.4 | 71.3 | 73.8 | 73.2 | | 78.0 |
| Income taxes | | 12.2 | 14.9 | 15.5 | 15.8 | 15.3 | | 15.9 |
| Tax rate | | 21.9% | 21.5% | 21.7% | 21.4% | 20.9% | | 20.4% |
| Minority interest | | 11.2 | 14.7 | 15.6 | 16.6 | 17.1 | | 18.5 |
| Net income | | 32.2 | 39.8 | 40.2 | 41.5 | 40.8 | | 43.6 |
| Net margin | | 5.8% | 7.3% | 7.6% | 8.1% | 8.2% | | 9.0% |
| |
| Basic EPS [+] | | $2.48 | $3.07 | $3.11 | $3.21 | $3.17 | | $3.39 |
| Growth | | -21.8% | -9.5% | -10.2% | -2.6% | 15.4% | | 44.3% |
| Diluted EPS [+] | | $2.48 | $3.07 | $3.11 | $3.21 | $3.17 | | $3.39 |
| Growth | | -21.8% | -9.5% | -10.2% | -2.6% | 15.4% | | 44.3% |
| |
| Dividends per share [+] | $0.00 | $1.64 | $1.61 | $1.58 | $1.52 | $1.46 | $0.00 | $1.08 |
| Growth | -100.0% | 12.3% | 49.1% | 125.7% | 334.3% | 356.3% | | 74.2% |
| |
| Shares outstanding (basic) [+] | | 13.0 | 13.0 | 12.9 | 12.9 | 12.9 | | 12.9 |
| Growth | | 0.7% | 0.6% | 0.6% | 0.5% | 0.5% | | 0.5% |
| Shares outstanding (diluted) [+] | | 13.0 | 13.0 | 12.9 | 12.9 | 12.9 | | 12.9 |
| Growth | | 0.7% | 0.6% | 0.6% | 0.5% | 0.5% | | 0.5% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |